NovaBay Pharmaceuticals, Inc. financial data

Symbol
NBY on NYSE
Industry
Pharmaceutical Preparations
Location
2000 Powell Street, Suite 1150, Emeryville, CA
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 129 % -44.5%
Quick Ratio 33.1 % -59.2%
Debt-to-equity 215 % +223%
Return On Assets -137 % -96.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4.89M shares +15.9%
Common Stock, Shares, Outstanding 1.35M shares -68%
Entity Public Float 3.05M USD -72%
Common Stock, Value, Issued 13K USD -98.1%
Weighted Average Number of Shares Outstanding, Basic 1.16M shares +1169%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 64K USD -53.6%
Selling and Marketing Expense 6.16M USD -0.34%
General and Administrative Expense 6.95M USD +3.86%
Operating Income (Loss) -8.69M USD +29.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -9.64M USD +9.13%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -10.7M USD +12%
Earnings Per Share, Basic 39.8 USD/shares +96.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 751K USD -83%
Accounts Receivable, after Allowance for Credit Loss, Current 547K USD
Inventory, Net 700K USD -80.9%
Other Assets, Current 94K USD -52.3%
Assets, Current 2.25M USD -79.9%
Property, Plant and Equipment, Net 68K USD -37%
Operating Lease, Right-of-Use Asset 1.13M USD -31.1%
Intangible Assets, Net (Excluding Goodwill) 0 USD -100%
Goodwill 0 USD -100%
Other Assets, Noncurrent 476K USD -4.03%
Assets 3.93M USD -75.5%
Accounts Payable, Current 1.24M USD -16.6%
Employee-related Liabilities, Current 380K USD -32.4%
Accrued Liabilities, Current 1.3M USD -52.9%
Contract with Customer, Liability, Current 4K USD -92.6%
Liabilities, Current 3.61M USD -40.5%
Contract with Customer, Liability, Noncurrent 0 USD
Operating Lease, Liability, Noncurrent 932K USD -32.4%
Liabilities 4.54M USD -39%
Retained Earnings (Accumulated Deficit) -180M USD -9.83%
Stockholders' Equity Attributable to Parent -617K USD -107%
Liabilities and Equity 3.93M USD -75.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.57M USD -32.4%
Net Cash Provided by (Used in) Financing Activities -597K USD
Net Cash Provided by (Used in) Investing Activities 1.07M USD
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 1.35M shares -68%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.31M USD +19.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.23M USD -74.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 236K USD
Deferred Tax Assets, Valuation Allowance 41M USD +9.66%
Deferred Tax Assets, Gross 41.4M USD +9.18%
Operating Lease, Liability 1.31M USD -29.2%
Depreciation 11K USD -15.4%
Payments to Acquire Property, Plant, and Equipment 2K USD -84.6%
Lessee, Operating Lease, Liability, to be Paid 1.41M USD -30.4%
Property, Plant and Equipment, Gross 764K USD +1.06%
Operating Lease, Liability, Current 382K USD -19.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 444K USD +1.14%
Lessee, Operating Lease, Liability, to be Paid, Year One 439K USD -21.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 92K USD -44.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 290K USD -34.7%
Deferred Tax Assets, Operating Loss Carryforwards 36.9M USD +4.85%
Preferred Stock, Shares Issued 1 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 974K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 290K USD -34.7%
Operating Lease, Payments 548K USD +15.9%
Additional Paid in Capital 179M USD +5.72%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 152K USD -58.1%
Depreciation, Depletion and Amortization 51K USD -57.5%
Share-based Payment Arrangement, Expense 267K USD +1171%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%